Effect of Azathioprine on Dogs with Immune-Mediated Hemolytic Anemia
Author Information
Author(s): Piek Christine J, van Spil Willem Evert, Junius Greet, Dekker Aldo
Primary Institution: Utrecht University
Hypothesis
Does the addition of azathioprine to prednisolone improve outcomes in dogs with idiopathic immune-mediated hemolytic anemia?
Conclusion
Azathioprine does not appear to provide a significant benefit as a standard treatment for all cases of immune-mediated hemolytic anemia in dogs.
Supporting Evidence
- The study included 222 dogs with a hematocrit lower than 0.30 L/L.
- No significant difference in survival was found between the two treatment groups.
- The 1-year survival was 64% in the P protocol group and 69% in the AP protocol group.
Takeaway
The study looked at whether a medicine called azathioprine helps dogs with a blood problem when given with another medicine called prednisolone. It found that azathioprine doesn't really help.
Methodology
Retrospective cohort study comparing outcomes of dogs treated with azathioprine and prednisolone versus prednisolone alone.
Potential Biases
Potential bias due to differences in treatment protocols over time.
Limitations
The study is retrospective, which may introduce bias, and it relies on historical controls.
Participant Demographics
222 dogs with idiopathic immune-mediated hemolytic anemia, including various breeds and both sexes.
Statistical Information
P-Value
0.65
Confidence Interval
95% CI 54 - 77% for P protocol group; 95% CI 59-80% for AP protocol group
Statistical Significance
p=0.65
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website